Fraud Blocker Peptide Research Library | Licensed Peptides
2 for 1 sale You pick the free one Any vial, any size. NO CODE, NO LIMITS. Extended sale ends in 4d 01h 55m 14s

Need help? Call Or Text us, and a team member will be happy to assist you. +1 (855) 322-2214

The Licensed Peptides research library is written and maintained by the Licensed Peptides research team. Articles summarise the published in-vitro and preclinical literature on the compounds Licensed Peptides supplies for laboratory research. They are written to a research-use-only standard: no dosing guidance, no human-use claims, and factual statements traced to the study they come from. Every article is reviewed for accuracy against the cited studies by Samuel Sarmiento, MD, MPH, MBA.

More about who writes and reviews this library

Search the Articles

Categories

Recent Posts

Articles by Licensed Peptides

  • ALL ARTICLES AND PRODUCT INFORMATION PROVIDED ON THIS WEBSITE ARE FOR INFORMATIONAL AND EDUCATIONAL PURPOSES ONLY. The products offered on this website are furnished for in-vitro studies only. In-vitro studies (Latin: in glass) are performed outside of the body. These products are not medicines or drugs and have not been approved by the FDA to prevent, treat or cure any medical condition, ailment or disease. Bodily introduction of any kind into humans or animals is strictly forbidden by law.

2810, 2025

Vasoactive Intestinal Peptide in Intervertebral Disc Degeneration Models: FGF18-FGFR2-AKT Signalling

By |10/28/2025|General Peptide Information|

Disclaimer: All articles and product details provided on this website are intended for educational and informational purposes only. The products listed here are for in-vitro research only. In-vitro studies are conducted outside of living organisms. These products are not intended as medicines or drugs and have not been approved by the FDA to prevent, treat, or cure any medical condition, ailment, or disease. The direct or indirect administration of these substances to humans or animals is unequivocally prohibited under applicable law. Background Intervertebral disc degeneration (IVDD) represents a major underlying cause of chronic low back pain. This condition is characterized...

2810, 2025

PEPITEM: Preclinical Research on Bone Remodeling

By |10/28/2025|General Peptide Information|

Disclaimer: All articles and product details provided on this website are intended for educational and informational purposes only. The products listed here are for in-vitro research only. In-vitro studies are conducted outside of living organisms. These products are not intended as medicines or drugs and have not been approved by the FDA to prevent, treat, or cure any medical condition, ailment, or disease. The direct or indirect administration of these substances to humans or animals is unequivocally prohibited under applicable law. Introduction PEPITEM (Peptide Inhibitor of Trans-Endothelial Migration), discovered in 2015 at the University of Birmingham, has recently been investigated...

2810, 2025

OS-01: Pan-AMPK Activator Research Overview

By |10/28/2025|General Peptide Information|

Disclaimer: All articles and product details provided on this website are intended for educational and informational purposes only. The products listed here are for in-vitro research only. In-vitro studies are conducted outside of living organisms. These products are not intended as medicines or drugs and have not been approved by the FDA to prevent, treat, or cure any medical condition, ailment, or disease. The direct or indirect administration of these substances to humans or animals is unequivocally prohibited under applicable law. Background: Type 2 Diabetes Research Context Type 2 Diabetes (T2D) remains one of the most pressing health concerns in...

2710, 2025

Klotho: Mechanisms, Physiological Roles, and Research Directions

By |10/27/2025|General Peptide Information|

Disclaimer: All articles and product details provided on this website are intended for educational and informational purposes only. The products listed here are for in-vitro research only. In-vitro studies are conducted outside of living organisms. These products are not intended as medicines or drugs and have not been approved by the FDA to prevent, treat, or cure any medical condition, ailment, or disease. The direct or indirect administration of these substances to humans or animals is unequivocally prohibited under applicable law. Introduction Klotho is a protein that has become a central focus in aging and chronic disease research. Discovered in...

2710, 2025

GHK-Cu in Inflammatory Disease Research: Emerging Findings

By |10/27/2025|General Peptide Information|

Disclaimer: All articles and product details provided on this website are intended for educational and informational purposes only. The products listed here are for in-vitro research only. In-vitro studies are conducted outside of living organisms. These products are not intended as medicines or drugs and have not been approved by the FDA to prevent, treat, or cure any medical condition, ailment, or disease. The direct or indirect administration of these substances to humans or animals is unequivocally prohibited under applicable law. Background GHK-Cu (Glycyl-L-histidyl-L-lysine bound to copper) is a naturally occurring tripeptide complex present in human plasma, saliva, and urine....

Stay Ahead of the Curve

Get exclusive updates on events, promotions, and special offers.

You cannot copy content of this page